Roivant Sciences ROIV
NASDAQ ROIV
$41.42 -0.06 (-0.16%)
As of: Sep 9, 2026 · 2:32 PM EDT

Roivant Sciences (ROIV) Depreciation & Amortization (CF) (2021 - 2026)

Roivant Sciences' (ROIV) quarterly Depreciation & Amortization (CF) came in at $600000.0 in Q2 2026, down 45.36% on a YoY basis from $1.1 million in Q2 2025, and down 77.86% quarter-over-quarter from $2.7 million in Q4 2025.

Analysis

Roivant Sciences (ROIV) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

Roivant Sciences (ROIV) has reported Depreciation & Amortization (CF) for 6 consecutive years, with $600000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Depreciation & Amortization (CF) fell 45.36% year-over-year to $600000.0; the trailing twelve-month figure through Jun 2026 stood at $4.2 million (down 77.24% YoY), and the FY2026 full-year result was $3.3 million, down 76.21% from the prior year.
  • Depreciation & Amortization (CF) slipped to $600000.0 in Q2 2026 per ROIV's latest filing, from $2.7 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $16.8 million in Q4 2023 and bottomed at $600000.0 in Q2 2026.
  • Historically, Depreciation & Amortization (CF) has averaged $5.9 million across 5 years, with a median of $4.9 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) jumped 205.35% in 2022, then tumbled 80.98% in 2025.
  • Over 5 years, Depreciation & Amortization (CF) stood at $12.9 million in 2022, then soared by 30.28% to $16.8 million in 2023, then decreased by 24.78% to $12.6 million in 2024, then sank by 78.57% to $2.7 million in 2025, then sank by 77.86% to $600000.0 in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $600000.0, $2.7 million, and $921000.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Amgen 212.13 Bn 198.14 Bn 7.24 Bn 1.11 Bn
2 Gilead Sciences 181.29 Bn 178.11 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.34 Bn 124.49 Bn 2.84 Bn 56.50 Mn
4 Regeneron Pharmaceuticals 82.70 Bn 74.71 Bn 3.93 Bn 123.70 Mn
5 Argenx Se 61.60 Bn 56.42 Bn 1.37 Bn -
6 Moderna 54.61 Bn 49.48 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.96 Bn 30.65 Bn 992.69 Mn -
8 Biogen 31.26 Bn 29.97 Bn 1.96 Bn 236.10 Mn
9 Roivant Sciences 29.96 Bn 29.96 Bn 1.16 Mn 600,000.00
10 Insmed 28.16 Bn 27.00 Bn 358.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 600,000.00
Dec 31, 2025 2.71 Mn
Sep 30, 2025 921,000.00
Jun 30, 2025 1.10 Mn
Dec 31, 2024 12.65 Mn
Sep 30, 2024 4.84 Mn
Jun 30, 2024 4.88 Mn
Dec 31, 2023 16.81 Mn
Sep 30, 2023 5.59 Mn
Jun 30, 2023 5.84 Mn
Dec 31, 2022 12.90 Mn
Sep 30, 2022 5.08 Mn
Jun 30, 2022 2.68 Mn
Dec 31, 2021 4.23 Mn